A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women

Nataki C. Douglas, Jeff G. Wang, Bo Yu, Sreedhar Gaddipati, Michael M. Guarnaccia, Mark V. Sauer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Nearly 130,000 American women are human immunodeficiency virus (HIV) seropositive. The present study sought to establish a comprehensive programme to address their fertility needs in order to minimize infectious, medical and reproductive risks to prospective patients. Forty women, aged 27-42 years, were evaluated. HIV was diagnosed 7.2 ± 0.7 years prior to their seeking care, and most women (n = 38) were on highly active antiretroviral therapy. Their prenatal CD4 counts were 712.2 ± 56 cells/mm3 (range 327-1881) and HIV-1 concentrations were undetectable in all cases prior to initiating treatment. HIV-seropositive women were statistically identical to their age-matched HIV-seronegative counterparts with respect to the IVF clinical outcome parameters measured. Throughout the pregnancies, maternal HIV-1 RNA concentrations remained undetectable and CD4 counts were stable. AU infants, tested at birth and at 3 and 6 months of age, remained HIV negative. This is the first report of an institutional paradigm in the USA dedicated to evaluate and treat HIV-seropositive women. Using a multidisciplinary approach to care, HIV-seropositive women may be successfully managed in a programme of assisted reproduction.

Original languageEnglish (US)
Pages (from-to)257-263
Number of pages7
JournalReproductive BioMedicine Online
Volume19
Issue number2
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

HIV
CD4 Lymphocyte Count
HIV-1
Highly Active Antiretroviral Therapy
Reproduction
Fertility
Mothers
Parturition
RNA
Pregnancy
Therapeutics

Keywords

  • Fertility
  • HIV-seropositive women
  • IVF

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women. / Douglas, Nataki C.; Wang, Jeff G.; Yu, Bo; Gaddipati, Sreedhar; Guarnaccia, Michael M.; Sauer, Mark V.

In: Reproductive BioMedicine Online, Vol. 19, No. 2, 08.2009, p. 257-263.

Research output: Contribution to journalArticle

Douglas, Nataki C. ; Wang, Jeff G. ; Yu, Bo ; Gaddipati, Sreedhar ; Guarnaccia, Michael M. ; Sauer, Mark V. / A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women. In: Reproductive BioMedicine Online. 2009 ; Vol. 19, No. 2. pp. 257-263.
@article{205229a53d404218a525acb59264b31e,
title = "A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women",
abstract = "Nearly 130,000 American women are human immunodeficiency virus (HIV) seropositive. The present study sought to establish a comprehensive programme to address their fertility needs in order to minimize infectious, medical and reproductive risks to prospective patients. Forty women, aged 27-42 years, were evaluated. HIV was diagnosed 7.2 ± 0.7 years prior to their seeking care, and most women (n = 38) were on highly active antiretroviral therapy. Their prenatal CD4 counts were 712.2 ± 56 cells/mm3 (range 327-1881) and HIV-1 concentrations were undetectable in all cases prior to initiating treatment. HIV-seropositive women were statistically identical to their age-matched HIV-seronegative counterparts with respect to the IVF clinical outcome parameters measured. Throughout the pregnancies, maternal HIV-1 RNA concentrations remained undetectable and CD4 counts were stable. AU infants, tested at birth and at 3 and 6 months of age, remained HIV negative. This is the first report of an institutional paradigm in the USA dedicated to evaluate and treat HIV-seropositive women. Using a multidisciplinary approach to care, HIV-seropositive women may be successfully managed in a programme of assisted reproduction.",
keywords = "Fertility, HIV-seropositive women, IVF",
author = "Douglas, {Nataki C.} and Wang, {Jeff G.} and Bo Yu and Sreedhar Gaddipati and Guarnaccia, {Michael M.} and Sauer, {Mark V.}",
year = "2009",
month = "8",
doi = "10.1016/S1472-6483(10)60082-X",
language = "English (US)",
volume = "19",
pages = "257--263",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A systematic, multidisciplinary approach to address the reproductive needs of HIV-seropositive women

AU - Douglas, Nataki C.

AU - Wang, Jeff G.

AU - Yu, Bo

AU - Gaddipati, Sreedhar

AU - Guarnaccia, Michael M.

AU - Sauer, Mark V.

PY - 2009/8

Y1 - 2009/8

N2 - Nearly 130,000 American women are human immunodeficiency virus (HIV) seropositive. The present study sought to establish a comprehensive programme to address their fertility needs in order to minimize infectious, medical and reproductive risks to prospective patients. Forty women, aged 27-42 years, were evaluated. HIV was diagnosed 7.2 ± 0.7 years prior to their seeking care, and most women (n = 38) were on highly active antiretroviral therapy. Their prenatal CD4 counts were 712.2 ± 56 cells/mm3 (range 327-1881) and HIV-1 concentrations were undetectable in all cases prior to initiating treatment. HIV-seropositive women were statistically identical to their age-matched HIV-seronegative counterparts with respect to the IVF clinical outcome parameters measured. Throughout the pregnancies, maternal HIV-1 RNA concentrations remained undetectable and CD4 counts were stable. AU infants, tested at birth and at 3 and 6 months of age, remained HIV negative. This is the first report of an institutional paradigm in the USA dedicated to evaluate and treat HIV-seropositive women. Using a multidisciplinary approach to care, HIV-seropositive women may be successfully managed in a programme of assisted reproduction.

AB - Nearly 130,000 American women are human immunodeficiency virus (HIV) seropositive. The present study sought to establish a comprehensive programme to address their fertility needs in order to minimize infectious, medical and reproductive risks to prospective patients. Forty women, aged 27-42 years, were evaluated. HIV was diagnosed 7.2 ± 0.7 years prior to their seeking care, and most women (n = 38) were on highly active antiretroviral therapy. Their prenatal CD4 counts were 712.2 ± 56 cells/mm3 (range 327-1881) and HIV-1 concentrations were undetectable in all cases prior to initiating treatment. HIV-seropositive women were statistically identical to their age-matched HIV-seronegative counterparts with respect to the IVF clinical outcome parameters measured. Throughout the pregnancies, maternal HIV-1 RNA concentrations remained undetectable and CD4 counts were stable. AU infants, tested at birth and at 3 and 6 months of age, remained HIV negative. This is the first report of an institutional paradigm in the USA dedicated to evaluate and treat HIV-seropositive women. Using a multidisciplinary approach to care, HIV-seropositive women may be successfully managed in a programme of assisted reproduction.

KW - Fertility

KW - HIV-seropositive women

KW - IVF

UR - http://www.scopus.com/inward/record.url?scp=69249139939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249139939&partnerID=8YFLogxK

U2 - 10.1016/S1472-6483(10)60082-X

DO - 10.1016/S1472-6483(10)60082-X

M3 - Article

VL - 19

SP - 257

EP - 263

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 2

ER -